253 related articles for article (PubMed ID: 28956113)
1. Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.
deSouza NM; Winfield JM; Waterton JC; Weller A; Papoutsaki MV; Doran SJ; Collins DJ; Fournier L; Sullivan D; Chenevert T; Jackson A; Boss M; Trattnig S; Liu Y
Eur Radiol; 2018 Mar; 28(3):1118-1131. PubMed ID: 28956113
[TBL] [Abstract][Full Text] [Related]
2. Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task force.
Sedlaczek OL; Kleesiek J; Gallagher FA; Murray J; Prinz S; Perez-Lopez R; Sala E; Caramella C; Diffetock S; Lassau N; Priest AN; Suzuki C; Vargas R; Giandini T; Vaiani M; Messina A; Blomqvist LK; Beets-Tan RGH; Oberrauch P; Schlemmer HP; Bach M;
Eur Radiol; 2022 Dec; 32(12):8617-8628. PubMed ID: 35678860
[TBL] [Abstract][Full Text] [Related]
3. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
[TBL] [Abstract][Full Text] [Related]
4. Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.
Michoux NF; Ceranka JW; Vandemeulebroucke J; Peeters F; Lu P; Absil J; Triqueneaux P; Liu Y; Collette L; Willekens I; Brussaard C; Debeir O; Hahn S; Raeymaekers H; de Mey J; Metens T; Lecouvet FE
Eur Radiol; 2021 Jul; 31(7):4514-4527. PubMed ID: 33409773
[TBL] [Abstract][Full Text] [Related]
5. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
[TBL] [Abstract][Full Text] [Related]
6. Technical Note: A safe, cheap, and easy-to-use isotropic diffusion MRI phantom for clinical and multicenter studies.
Pullens P; Bladt P; Sijbers J; Maas AI; Parizel PM
Med Phys; 2017 Mar; 44(3):1063-1070. PubMed ID: 28079257
[TBL] [Abstract][Full Text] [Related]
7. Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom.
Malyarenko D; Galbán CJ; Londy FJ; Meyer CR; Johnson TD; Rehemtulla A; Ross BD; Chenevert TL
J Magn Reson Imaging; 2013 May; 37(5):1238-46. PubMed ID: 23023785
[TBL] [Abstract][Full Text] [Related]
8. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
Giganti F; Salerno A; Ambrosi A; Chiari D; Orsenigo E; Esposito A; Albarello L; Mazza E; Staudacher C; Del Maschio A; De Cobelli F
Radiol Med; 2016 Mar; 121(3):173-80. PubMed ID: 26392393
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance multicenter comparison of different MR scanners for quantitative diffusion-weighted imaging.
Belli G; Busoni S; Ciccarone A; Coniglio A; Esposito M; Giannelli M; Mazzoni LN; Nocetti L; Sghedoni R; Tarducci R; Zatelli G; Anoja RA; Belmonte G; Bertolino N; Betti M; Biagini C; Ciarmatori A; Cretti F; Fabbri E; Fedeli L; Filice S; Fulcheri CP; Gasperi C; Mangili PA; Mazzocchi S; Meliadò G; Morzenti S; Noferini L; Oberhofer N; Orsingher L; Paruccini N; Princigalli G; Quattrocchi M; Rinaldi A; Scelfo D; Freixas GV; Tenori L; Zucca I; Luchinat C; Gori C; Gobbi G;
J Magn Reson Imaging; 2016 Jan; 43(1):213-9. PubMed ID: 26013043
[TBL] [Abstract][Full Text] [Related]
11. Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development.
Sinkus R; Van Beers BE; Vilgrain V; DeSouza N; Waterton JC
Eur J Cancer; 2012 Mar; 48(4):425-31. PubMed ID: 22226479
[TBL] [Abstract][Full Text] [Related]
12. How reliable are ADC measurements? A phantom and clinical study of cervical lymph nodes.
Moreau B; Iannessi A; Hoog C; Beaumont H
Eur Radiol; 2018 Aug; 28(8):3362-3371. PubMed ID: 29476218
[TBL] [Abstract][Full Text] [Related]
13. Coronal diffusion-weighted magnetic resonance imaging of the kidney: agreement with axial diffusion-weighted magnetic imaging in terms of apparent diffusion coefficient values.
Wang HY; Wang J; Tang YH; Ye HY; Ma L
Chin Med J (Engl); 2015 Feb; 128(4):499-503. PubMed ID: 25673453
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Absolute Apparent Diffusion Coefficient (ADC) Values in ADC Maps Generated Across Different Postprocessing Software: Reproducibility in Endometrial Carcinoma.
Ghosh A; Singh T; Singla V; Bagga R; Khandelwal N
AJR Am J Roentgenol; 2017 Dec; 209(6):1312-1320. PubMed ID: 28952809
[TBL] [Abstract][Full Text] [Related]
15. The reliability of routine clinical post-processing software in assessing potential diffusion-weighted MRI "biomarkers" in brain metastases.
Zakaria R; Das K; Bhojak M; Radon M; Sluming V; Walker C; Jenkinson MD
Magn Reson Imaging; 2014 Apr; 32(3):291-6. PubMed ID: 24462300
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging in pediatric body magnetic resonance imaging.
Chavhan GB; Caro-Dominguez P
Pediatr Radiol; 2016 May; 46(6):847-57. PubMed ID: 27229502
[TBL] [Abstract][Full Text] [Related]
17. Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
Aydin H; Guner B; Esen Bostanci I; Bulut ZM; Aribas BK; Dogan L; Gulcelik MA
Br J Radiol; 2018 Apr; 91(1084):20170705. PubMed ID: 29299933
[TBL] [Abstract][Full Text] [Related]
18. Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the american college of radiology imaging network 6698 breast cancer trial.
Newitt DC; Tan ET; Wilmes LJ; Chenevert TL; Kornak J; Marinelli L; Hylton N
J Magn Reson Imaging; 2015 Oct; 42(4):908-19. PubMed ID: 25758543
[TBL] [Abstract][Full Text] [Related]
19. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter?
Maier SE; Wallström J; Langkilde F; Johansson J; Kuczera S; Hugosson J; Hellström M
J Magn Reson Imaging; 2022 Mar; 55(3):842-853. PubMed ID: 34535940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]